The firstinAfrica ex vivo drug sensitivity testing platform identifies novel drug combinations for South African leukaemia patient cohort

dc.article.end-page11en
dc.article.start-page1en
dc.citation.doi10.1038/S41598-025-93634-Wen
dc.contributor.authorVanelle Larissa Kenmogneen
dc.contributor.authorM M Takundwaen
dc.contributor.authorEkene Nwekeen
dc.contributor.authorB Monchusien
dc.contributor.authorP Dubeen
dc.contributor.authorHeather Maheren
dc.contributor.authorJacques Du Toiten
dc.contributor.authorVinitha Philip-Cherianen
dc.contributor.authorPascaline Fruen
dc.contributor.authorDeepak Thimirien
dc.date.accessioned2026-03-30T09:42:47Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.urihttps://hdl.handle.net/10539/48788
dc.journal.titleThe firstinAfrica ex vivo drug sensitivity testing platform identifies novel drug combinations for South African leukaemia patient cohorten
dc.journal.volume15en
dc.titleThe firstinAfrica ex vivo drug sensitivity testing platform identifies novel drug combinations for South African leukaemia patient cohorten
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
5.3 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client